Medications on the Horizon

These are investigational medications in clinical trials and regulatory review that we're monitoring for possible future availability. Timelines and outcomes can change.

Earlier Stage

2028+

Earlier-stage compounds we are monitoring. The science is still evolving, and timelines and outcomes remain uncertain.

Clascoterone Solution

Hair Loss

Clascoterone 7.5% topical solution

Clascoterone is FDA-approved for acne and is being studied for hair-related use. Varus currently offers information and waitlist updates only.

Pipeline information is based on publicly available clinical trial data and company announcements. Estimated timelines are subject to change. Varus does not guarantee availability of any pipeline treatment. Join the waitlist to be notified when treatments become available through our platform.